Filter posts

Curative Therapies: Aligning Policy with Science to Ensure Patient Access

New hepatitis C medications with exceptionally high cure rates have significantly improved treatment, while also …

Facts Not Fiction: Digital Delivers Results for Biotech Companies

A panel of experts in the digital advertising space assembled Wednesday at the 2016 BIO International …

Antibiotic Development Incentives May Be Tricky to Implement

A recently proposed broad suite of antibiotic development incentives has received strong support from industry …

#BIO2016 Keynote: A Look at the 2016 Presidential Election

Who will be the next president of the United States was the topic of Wednesday’s …

My Keynote Address at the 2016 BIO International Convention

Yesterday, the voters of California had their say. The general election is upon us. It’s …

Janet Napolitano and Jim Greenwood Talk Innovation, Homeland Security, and Politics at #BIO2016 Fir...

Janet Napolitano, President of the University of California, emphasized the need for research at every …

Achieving Healthcare Sustainability: Can we Move from “Value” to “Predictability”?

Drug costs are one of largest healthcare concerns across the American political spectrum. But drug …

Shifting CAR-Ts Into a Higher Gear

After a three-year run-up of mounting excitement over CAR-T therapies comes crunch time. Over the …

Virtual Reality Meets the Operating Room: Digital Health Summer Summit Audience Experiences a Live S...

If you thought Virtual Reality was just something to be used at the movies or …

USTR Chief Ag Negotiator Keynotes #BIO2016 Food and Agriculture Track

On Tuesday, June 09, 2016, Ambassador Darci Vetter, Chief Agricultural Negotiator for the U.S. Trade Representative, …